the motility pattern (1) (2) (3) (4) . The bacterial toxins stimulate migrating contractions that propulse the increased secretions through the intestinal tract (3, 4) . Thus, in patients with infectious diarrhea, the increase in luminal fluid accumulation and the alteration in bowel motility may act together to cause severe diarrhea.
Deoxycholic acid (DCA)' stimulates increased colonic contractility in patients with the irritable bowel syndrome and reproduces their symptoms (5) . DCA increases the colonic mucosal secretion and stimulates a propulsive migrating motor complex in the colon (5) (6) (7) (8) (9) . The increase in mucosal secretion caused by DCA is related to an increase in intracellular cyclic 3'5' AMP that can be inhibited by the administration of propranolol (10, 11) . Similar to infectious diarrhea, the simultaneous presence of both secretory and motor abnormalities might lead to a greater degree of diarrhea.
The mechanism of the migrating action potential complex (MAPC) stimulated by DCA is presently unclear. The purpose of this study was to determine the mechanism of DCA-stimulated MAPC activity. Clarification of the mechanism of the motility disorder associated with a bile salt abnormality may help therapeutically in patients with bile acid associated gastrointestinal motility dysfunction.
METHODS
Studies were performed on 43 male New Zealand White rabbits weighing 2.5-3.8 kg. The rabbits were initially tranquilized with Innovar (0.2 ml/kg intramuscular) (PitmanMoore, Inc., Washington Crossing, NJ) and anesthetized with sodium pentobarbital (25 mg/kg) administered intravenously through the ear vein. A tracheostomy was performed in each animal and respiratory activity was controlled by a small animal respirator (Harvard Apparatus Respirator, Harvard Apparatus Co., Inc., S. Natick, MA). 15 .1±2.4/h (P < 0.001). After adding DCA, the velocity of the MAPC increased to 16.6±1.4 mm/s (P < 0.005) and the duration of the MAPC decreased to 12.1±1.0 s (P < 0.025). Fig. 2 shows a myoelectrical recording from a colonic loop that had been stimulated by DCA. Procaine was added intraluminally at the arrow. After adding DCA, MAPC are stimulated with concurrent migrating contractions. The addition of procaine totally abolished the MAPC activity that had been stimulated by DCA within 1 min. No MAPC activity occurred after adding procaine intraluminally. Fig. 3 shows the number of MAPC after adding DCA alone or after the simultaneous administration of the antagonists, procaine, intraluminally-or atropine, phentolamine, or propranolol, intravenously. DCA increased the MAPC activity to 15.1±2.4 MAPC/h (P < 0.001). The intraluminal administration of procaine reduced DCA-stimulated MAPC activity (0.2±0.2 MAPC/h) (P < 0.005). In two animals intraluminal tetrodotoxin also abolished DCA-stimulated MAPC activity. Atropine infusion reduced the MAPC frequency to 0.3±0.3 MAPC/h (P < 0.025). Phentolamine (1.0 mg/kg) an alpha adrenergic antagonist, similarly reduced the MAPC frequency to 0.3±0.3 MAPC/h (P <0.005). A lower concentration of phentolamine (0.25 mg/kg) also completely inhibited the MAPC activity. Sympathetic denervation wth 6-hydroxydopamine prevented an increase in MAPC activity after DCA. However, after the administration of the beta adrenergic antagonist, propranolol, DCA continued to stimulate colonic MAPC activity (9.8±1.4 MAPC/h) (P < 0.001). Fig. 4 shows a myoelectrical recording after MAPC activity has been stimulated by the intraluminal administration of 16 mM DCA. Trimethaphan camsylate was infused intravenously at a rate of 4 mg/min. This dose of trimethaphan decreased the blood pressure, but had no effect on the MAPC activity. Fig. 5 shows the effect on MAPC activity of DCA alone and the simultaneous administration of DCA and trimethaphan camsylate. DCA increases the MAPC activity from 1.2±0.7 MAPC/10 min to 3.5±0.6 MAPC/10 min (P < 0.01). Ganglionic blockade with trimethaphan camsylate did not block the DCA stimulation of MAPC activity 2.5±1.3 MAPC/10 min (P > 0.05). Similar results were obtained after the administration of hexamethonium in two studies (2.4±0.1 MAPC/10 min). Hexamethonium also decreased the systemic blood pressure, but had no effect on DCAstimulated MAPC activity. Fig. 6 shows the plasma bile acid concentration obtained from the mesenteric vein draining the colonic loop and from the femoral artery. After saline administration to the colonic loop, the plasma bile acid concentration was 13.3±1.7 ,uM from the mesenteric venous outflow and 4.9±0.4 uM from the femoral artery. After adding 16 mM DCA into the colonic loop, the plasma bile acid concentration in the mesenteric venous blood flowing from the loops increased to 150±26.3 MM (P < 0.001). The plasma bile acid concentration in the femoral arterial blood did not change from basal levels after the administration of 16 DCA was infused intravenously to assess the effect of high intravascular concentrations of DCA. lated to the concentration and the total duration of the mucosal exposure to DCA (8) . The purpose of these studies was to determine the mechanism through which DCA stimulated the colonic smooth muscle MAPC activity.
Mucosal contact by the DCA appears to be essential for the stimulation of colonic MAPC activity. The increase in MAPC activity occurred only within the smooth muscle included in the colonic loop and did not occur in the colon excluded from the loop containing DCA. In addition, intravenous infusion of DCA failed to stimulate colonic MAPC activity despite similar concentrations within the serum in the mesenteric vein. Thus, the effect of DCA on colonic smooth muscle appears to be a local phenomenon and the receptors that are sensitive to DCA seem to be present in the wall of the colonic loop.
DCA appears to stimulate MAPC activity within the colonic loop through a neural mechanism. Procaine is a local anaesthetic that acts as an antagonist of local neural reflexes (14, 15) . Procaine blocks excitation of the neural membrane. The small diameter sensory afferent nerves are affected quickly (15) . The intraluminal administration of procaine inhibited DCA-stimulated MAPC activity, despite the continued presence of DCA within the loop. Procaine possibly inhibits the DCA stimulation of MAPC activity by blocking the afferent neural receptors present within the mucosa or submucosa of the colonic loop or by blocking the transmission of impulses through the myenteric plexus. Because procaine inhibited the generation of DCAstimulated MAPC activity, continuous stimulation of the neural receptors appears necessary for sustained MAPC activity. Inhibition of the DCA-stimulated MAPC activity by the local administration of tetrodotoxin confirms the importance of local neural reflexes in the generation of the MAPC activity.
Stimulation of colonic MAPC activity by DCA appears to require intact cholinergic and alpha adrenergic neural pathways. Both atropine, a muscarinic antagonist, and phentolamine, an alpha adrenergic antagonist, inhibit DCA stimulation of MAPC activity. Beta adrenergic blockade with propranolol does not alter DCA-stimulated MAPC activity. Ganglionic blockade by trimethaphan or hexamethonium also had no effect on DCA stimulation of MAPC activity. Trimethaphan and hexamethonium have their major antagonist effect on nicotinic-cholinergic synaptic junctions (16) . The neural receptor antagonist drugs were used at doses that blocked the action of the agonist. Thus, these data suggest that DCA stimulated a neural reflex that requires intact muscarinic-cholinergic neurons and alpha adrenergic neurons, but does not require a synapse through a nicotinic-cholinergic junction.
These data suggest a complicated neural pathway. A muscarinic-cholinergic neuron may synapse with an adrenergic interneuron whose neurotransmission to a postganglionic neuron can be blocked with alpha adrenergic antagonists (17) . This mechanism is consistent with the importance of muscarinic and alpha adrenergic receptors in DCA stimulation of the colonic loop and with the lack of an effect by the blockade of nicotinic ganglionic synapses.
DCA stimulation of colonic MAPC activity differs from DCA stimulation of colonic mucosal secretion. DCA stimulates mucosal secretion through an increase in adenylate cyclase, which is mediated through the beta adrenergic system (6, 10) . Propranolol inhibits the increase in colonic mucosal secretion, but it has no effect on DCA stimulation of motor activity.
After demonstrating the importance of the neural pathways for DCA stimulation of the colon, it was necessary to evaluate the direct effect of high serum levels of DCA on the colonic smooth muscle. When the serum levels of DCA were increased to the level Mechanism of Deoxycholic Acid Stimulation of the Colon l observed in the mesenteric venous blood, there was no increase in the number of MAPC. Despite the local increase in serum and tissue levels of DCA, the binding of DCA to local intraluminal neural receptors appears to be most important.
These studies suggest that in addition to the known secretory response that occurs due to exposure to excessive luminal concentrations of dihydroxy bile salts in the colon, there is a locally initiated, neurally mediated abnormal colonic motor pattern. This response differs from the secretory response because the motor response can be inhibited by muscarinic or alpha adrenergic blockade rather than beta adrenergic blockade.
